{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T10:31:13Z","timestamp":1782556273660,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009469","name":"Region Centre-Val de Loire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018833","name":"AID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ejmech.2024.116412","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T16:12:03Z","timestamp":1713197523000},"page":"116412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Synthesis of LAVR-289, a new [(Z)-3-(acetoxymethyl)-4-(2,4-diaminopyrimidin-6-yl)oxy-but-2-enyl]phosphonic acid prodrug with pronounced antiviral activity against DNA viruses"],"prefix":"10.1016","volume":"271","author":[{"given":"Maximes","family":"Bessi\u00e8res","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuniyazi","family":"Abuduani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Favetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Andrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Moffat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6083-0810","authenticated-orcid":false,"given":"Luigi A.","family":"Agrofoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116412_bib1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/323464a0","article-title":"A novel selective broad-spectrum anti-DNA virus agent","volume":"323","author":"De Clercq","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2024.116412_bib2","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd1877","article-title":"Acyclic nucleoside phosphonates: a key class of antiviral drugs","volume":"4","author":"De Clercq","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116412_bib3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.bcp.2006.09.014","article-title":"Acyclic nucleoside phosphonates: past, present and future. Bridging chemistry to HIV, HBV, HCV, HPV, adeno-, herpes-, and poxvirus infections: the phosphonate bridge","volume":"7","author":"De Clercq","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116412_bib4","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.3390\/v14091978","article-title":"The elegance of the acyclic nucleoside phosphonates (ANPs), honorary tribute to Anton\u00edn Hol\u00fd, who passed away on 16 July 2012, at the 10th anniversary of his death","volume":"14","author":"De Clercq","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2024.116412_bib5","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/med.21296","article-title":"Medicinal chemistry of fluorinated cyclic and acyclic nucleoside phosphonates","volume":"33","author":"Baszczy\u0148ski","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2024.116412_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjp.0706446","article-title":"Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy","volume":"147","author":"De Clercq","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116412_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.889737","article-title":"Phosphonates and phosphonate prodrugs in medicinal chemistry: past successes and future prospects","volume":"10","author":"Kre\u010dmerov\u00e1","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2024.116412_bib8","doi-asserted-by":"crossref","first-page":"9154","DOI":"10.1021\/cr5002035","article-title":"Synthesis of nucleoside phosphate and phosphonate prodrugs","volume":"114","author":"Pradere","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2024.116412_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0166-3542(92)90084-I","article-title":"Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine","volume":"19","author":"Jr Starrett","year":"1992","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2024.116412_bib10","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/AAC.42.7.1568","article-title":"Antiretroviral efficacy and pharmacokinetics of oral bis(isopropyloxycarbonyloxymethyl)-9-(2-phosphonylmethoxypropyl)adenine in mice","volume":"42","author":"Naesens","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116412_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2015.11.009","article-title":"Tenofovir alafenamide: a novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus","volume":"125","author":"Ray","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2024.116412_bib12","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejmech.2018.01.086","article-title":"Highly convergent synthesis and antiviral activity of (E)-but-2-enyl nucleoside phosphonoamidates","volume":"146","author":"Bessi\u00e8res","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116412_bib13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1021\/jm1011462","article-title":"Novel antiviral C5-substituted pyrimidine acyclic nucleoside phosphonates selected as human thymidylate kinase substrates","volume":"54","author":"Topalis","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116412_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116351","article-title":"Synthesis of acyclic nucleoside phosphonates targeting flavin-dependent thymidylate synthase in Mycobacterium tuberculosis","volume":"46","author":"Biteau","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116412_bib15","doi-asserted-by":"crossref","first-page":"67398","DOI":"10.1016\/j.ejmech.2013.06.053","article-title":"Synthesis and broad spectrum antiviral evaluation of bis(POM) prodrugs of novel acyclic nucleosides","volume":"67","author":"Hamada","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116412_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117508","article-title":"Discovery of a potent and selective human AC2 inhibitor based on 7-deazapurine analogues of adefovir","volume":"95","author":"Kraina","year":"2023","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116412_bib17","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1021\/acs.jmedchem.1c01881","article-title":"Stereo-defined acyclic nucleoside phosphonates are selective and potent inhibitors of parasite 6-oxopurine phosphoribosyltransferases","volume":"65","author":"Klejch","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116412_bib18","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1039\/D1OB00751C","article-title":"Diverse synthetic approaches towards C1'-branched acyclic nucleoside phosphonates","volume":"19","author":"Kal\u010dic","year":"2021","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2024.116412_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jac\/dkl454","article-title":"Pronounced in vitro and in vivo antiretroviral activity of 5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines","volume":"59","author":"Balzarini","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2024.116412_bib20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1081\/NCN-200059772","article-title":"Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines","volume":"24","author":"De Clercq","year":"2005","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.ejmech.2024.116412_bib21","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1021\/jm030932o","article-title":"5-Substituted-2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidines-acyclic nucleoside phosphonate analogues with antiviral activity","volume":"46","author":"Hockov\u00e1","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116412_bib22","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1081\/NCN-200027573","article-title":"6-[2-phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines: a new class of acyclic pyrimidine nucleoside phosphonates with antiviral activity","volume":"23","author":"Balzarini","year":"2004","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.ejmech.2024.116412_bib23","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1074\/jbc.M109.096529","article-title":"The acyclic 2,4-diaminopyrimidine nucleoside phosphonate acts as a purine mimetic in HIV-1 reverse transcriptase DNA polymerization","volume":"285","author":"Herman","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116412_bib24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3851\/IMP2012","article-title":"Medicinal chemistry of nucleoside phosphonate prodrugs for antiviral therapy","volume":"22","author":"Pertusati","year":"2012","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.ejmech.2024.116412_bib25","first-page":"A84","article-title":"Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art, Antiviral","volume":"82","author":"Hostetler","year":"2009","journal-title":"Res."},{"key":"10.1016\/j.ejmech.2024.116412_bib26","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1128\/AAC.00918-08","article-title":"Inhibition of herpesvirus replication by hexadecyloxypropyl esters of purine- and pyrimidine-based phosphonomethoxyethyl nucleoside phosphonates","volume":"52","author":"Prichard","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116412_bib27","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1128\/AAC.46.8.2381-2386.2002","article-title":"Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro","volume":"46","author":"Beadle","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2024.116412_bib28","doi-asserted-by":"crossref","first-page":"11360","DOI":"10.1021\/ja0214882","article-title":"A general model for selectivity in olefin cross metathesis","volume":"125","author":"Chatterjee","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116412_bib29","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1135\/cccc19872801","article-title":"Synthesis of 9-(2-phosphonylmethoxyethyl)adenine and related compunds","volume":"52","author":"Hol\u00fd","year":"1987","journal-title":"Collect. Czech Chem. Commun."},{"key":"10.1016\/j.ejmech.2024.116412_bib30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10529-012-1124-z","article-title":"Chemoselective acylation of (hydroxyalkyl)phenols catalyzed by Candida Antarctica lipase B","volume":"35","author":"Miyazawa","year":"2013","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.ejmech.2024.116412_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0022-328X(01)01269-4","article-title":"The Cl2(PCy3)(IMes)Ru(=CHPh) catalyst: olefin metathesis versus olefin isomerization","volume":"643\u2013644","author":"Bourgeois","year":"2002","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.ejmech.2024.116412_bib32","doi-asserted-by":"crossref","first-page":"59747","DOI":"10.1039\/C4RA13033B","article-title":"A convenient, highly selective and eco-friendly N-Boc protection of pyrimidines under microwave irradiation","volume":"4","author":"Bessi\u00e8res","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2024.116412_bib33","first-page":"14.11.1","article-title":"Olefin cross-metathesis for the synthesis of alkenyl acyclonucleoside phosphonates, Curr. Protoc. Nucleic Acid","volume":"59","author":"Bessi\u00e8res","year":"2014","journal-title":"Chem"},{"key":"10.1016\/j.ejmech.2024.116412_bib34","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1002\/ejoc.201101111","article-title":"The shortest strategy for generating phosphonate prodrugs by olefin cross-metathesis \u2013 Application to acyclonucleoside phosphonates","volume":"36","author":"Prad\u00e8re","year":"2011","journal-title":"Eur. J. Org. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424002927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424002927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T09:34:04Z","timestamp":1717234444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424002927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":34,"alternative-id":["S0223523424002927"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116412","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of LAVR-289, a new [(Z)-3-(acetoxymethyl)-4-(2,4-diaminopyrimidin-6-yl)oxy-but-2-enyl]phosphonic acid prodrug with pronounced antiviral activity against DNA viruses","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116412"}}